Shares of Cassava Sciences Inc (SAVA) are trading 16% higher at a price of $20.35 at the time of this writing.

Cassava Sciences Inc has been trading between a 52-week high of $126.51 and a 52-week low of $13.84. The stock has a market cap of $816 Million.

Cassava Sciences' mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to develop novel solutions for Alzheimer's disease.

Cassava Sciences Stock: Learnings From Q2 2022 Earnings
Seeking Alpha 08-04-22

Cassava Sciences Inc. (NASDAQ: SAVA) Stock: Boom Or Bust? What Happens Next?
Marketing Sentinel 08-04-22

Cassava Sciences: Q2 Earnings Insights
Benzinga 08-03-22

Cassava Sciences Reports Second Quarter Financial Results, Interim Analysis of Open-label Study By Investing.com
Investing.com 08-03-22

Cassava Sciences GAAP EPS of -$0.48 misses by $0.06
Seeking Alpha 08-03-22


As you can imagine, the internet had a few things to say about the price move. Here's a few choice comments from the Reddit Traderverse™:

NababboAChi - 2 upvotes - source
Why do you have to humiliate me  SENS at 3.24 PLTR at 21.60 SAVA at 52 (the biggest part is in a world etf btw) ​ But I made some good money with GME (which I'd like to repeat) so overall I'm in green. Sad but green.

NababboAChi - 2 upvotes - source
Sorry about GME. I'm keeping my SAVA bags. I hope for a pump after CUNY releases some information (good I hope) to sell.